Stratec Biomedical AG Stock Xetra
Equities
DE0007289001
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
Apr. 29 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
Apr. 26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
Sales 2024 * | 266M 287M | Sales 2025 * | 290M 312M | Capitalization | 497M 535M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.25M | Net income 2025 * | 23M 24.79M | EV / Sales 2024 * | 2.31 x |
Net Debt 2024 * | 116M 125M | Net Debt 2025 * | 79.62M 85.84M | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
30.4
x | P/E ratio 2025 * |
21.4
x | Employees | - |
Yield 2024 * |
2.13% | Yield 2025 * |
2.22% | Free-Float | 59.43% |
Latest transcript on Stratec Biomedical AG
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 98-02-28 |
Robert Siegle
DFI | Director of Finance/CFO | 57 | 98-04-30 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 58 | 19-05-28 |
Georg Heni
CHM | Chairman | 66 | 22-05-19 |
Rolf Vornhagen
BRD | Director/Board Member | 71 | 20-07-20 |
1st Jan change | Capi. | |
---|---|---|
+8.88% | 221B | |
+8.68% | 186B | |
+14.25% | 137B | |
+28.18% | 109B | |
+14.65% | 52.68B | |
+4.48% | 50.86B | |
+4.39% | 42.53B | |
+7.00% | 37.76B | |
+26.06% | 31.86B |